- Home
- KSCP vs COEP Comparison
KSCP vs COEP Comparison
Compare KSCP & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KSCP
- COEP
- Stock Information
- Founded
- KSCP 2013
- COEP 2017
- Country
- KSCP United States
- COEP United States
- Employees
- KSCP N/A
- COEP N/A
- Industry
- KSCP Telecommunications Equipment
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KSCP Telecommunications
- COEP Health Care
- Exchange
- KSCP Nasdaq
- COEP Nasdaq
- Market Cap
- KSCP 29.3M
- COEP 32.0M
- IPO Year
- KSCP 2022
- COEP N/A
- Fundamental
- Price
- KSCP $6.27
- COEP $8.95
- Analyst Decision
- KSCP Strong Buy
- COEP
- Analyst Count
- KSCP 3
- COEP 0
- Target Price
- KSCP $15.67
- COEP N/A
- AVG Volume (30 Days)
- KSCP 202.2K
- COEP 28.9K
- Earning Date
- KSCP 05-14-2025
- COEP 05-14-2025
- Dividend Yield
- KSCP N/A
- COEP N/A
- EPS Growth
- KSCP N/A
- COEP N/A
- EPS
- KSCP N/A
- COEP N/A
- Revenue
- KSCP $11,468,000.00
- COEP $62,874.00
- Revenue This Year
- KSCP $16.17
- COEP N/A
- Revenue Next Year
- KSCP $39.02
- COEP N/A
- P/E Ratio
- KSCP N/A
- COEP N/A
- Revenue Growth
- KSCP N/A
- COEP N/A
- 52 Week Low
- KSCP $2.45
- COEP $2.31
- 52 Week High
- KSCP $28.57
- COEP $13.70
- Technical
- Relative Strength Index (RSI)
- KSCP 60.66
- COEP 45.20
- Support Level
- KSCP $5.91
- COEP $9.14
- Resistance Level
- KSCP $6.49
- COEP $9.82
- Average True Range (ATR)
- KSCP 0.42
- COEP 0.54
- MACD
- KSCP -0.01
- COEP -0.06
- Stochastic Oscillator
- KSCP 81.51
- COEP 21.51
About KSCP Knightscope Inc.
Knightscope Inc is a security technology company based in Silicon Valley. It designs, develops, manufactures, markets, and supports Autonomous Security Robots (ASRs), autonomous charging stations, the proprietary Knightscope Security Operations Center software user interface, Emergency Communication Devices platform with real-time on-site data collection and analysis and a proprietary interface for both indoor and outdoor usage. In addition, it developed and operates the Knightscope Security Operations Center (KSOC) which allows real-time data access, a service accessible to all its clients.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.